Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry
The capacity for quantification of active metabolites of vitamin D (VitD) is highly valuable to evaluate the risks and therapies for numerous diseases such as multiple sclerosis. However, the extremely low circulating levels and poor detectability of some dihydroxyl metabolites such as the 1alpha,25...
Uložené v:
| Vydané v: | Analytical chemistry (Washington) Ročník 82; číslo 6; s. 2488 |
|---|---|
| Hlavní autori: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
15.03.2010
|
| Predmet: | |
| ISSN: | 1520-6882, 1520-6882 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The capacity for quantification of active metabolites of vitamin D (VitD) is highly valuable to evaluate the risks and therapies for numerous diseases such as multiple sclerosis. However, the extremely low circulating levels and poor detectability of some dihydroxyl metabolites such as the 1alpha,25-dihydroxy-VitD(3) constitute a daunting challenge. Based on the combination of a selective solid-phase extraction (SPE) and a microflow liquid chromatography tandem mass spectrometry (microLC-MS/MS), we developed an ultrasensitive method for the robust, selective, and accurate quantification of four key VitD metabolites, including 25-hydroxy-VitD(2), 25-hydroxy-VitD(3), 24(R),25-dihydroxy-VitD(3), and 1alpha,25-dihydroxy-VitD(3), in serum samples. A one-step derivatization was employed to improve the ionization efficiency of the metabolites. The SPE procedure was optimized so that the analytes were selectively extracted from serum, while the sample matrix was substantially simplified. By eliminating majority of undesirable compounds from the matrix, the selective SPE enabled a high sample loading volume on the microLC column without causing overcapacity of the microLC column and thus helped to achieve ultralow detect limits in serum. An on-column sample focusing approach was employed to prevent band-broadening, and a sufficient microLC separation was achieved to eliminate endogenous interferences and to minimize ion suppression effect. Detect limits of the four metabolites ranged from 0.5-1 pg/mL, and the linearity was excellent for all compounds. The method showed high quantitative accuracy (error < 13.8%) and precision (CV < 14.1%). For 1alpha,25-dihydroxy-VitD(3), a lower limit of quantification (LLOQ) of 5 pg/mL was validated. This high level of sensitivity, for the first time, enabled the robust and consistent LC/MS/MS-based analysis of the four metabolites in a large-scale clinical investigation. Serum samples from 281 multiple sclerosis patients and 22 healthy subjects were analyzed, and it was discovered that the levels of both 24(R),25-dihydroxy-VitD(3) and 1alpha,25-dihydroxy-VitD(3) were significantly lower in patients than healthy subjects (P < 0.05). This novel observation may imply that the incidence of multiple sclerosis is inversely associated with the levels of the two metabolites. Moreover, the method was highly robust and reproducible as evaluated extensively in the clinical analysis; therefore, it could serve as a more selective and accurate alternative to immunoassay for large-scale clinical studies. |
|---|---|
| AbstractList | The capacity for quantification of active metabolites of vitamin D (VitD) is highly valuable to evaluate the risks and therapies for numerous diseases such as multiple sclerosis. However, the extremely low circulating levels and poor detectability of some dihydroxyl metabolites such as the 1alpha,25-dihydroxy-VitD(3) constitute a daunting challenge. Based on the combination of a selective solid-phase extraction (SPE) and a microflow liquid chromatography tandem mass spectrometry (microLC-MS/MS), we developed an ultrasensitive method for the robust, selective, and accurate quantification of four key VitD metabolites, including 25-hydroxy-VitD(2), 25-hydroxy-VitD(3), 24(R),25-dihydroxy-VitD(3), and 1alpha,25-dihydroxy-VitD(3), in serum samples. A one-step derivatization was employed to improve the ionization efficiency of the metabolites. The SPE procedure was optimized so that the analytes were selectively extracted from serum, while the sample matrix was substantially simplified. By eliminating majority of undesirable compounds from the matrix, the selective SPE enabled a high sample loading volume on the microLC column without causing overcapacity of the microLC column and thus helped to achieve ultralow detect limits in serum. An on-column sample focusing approach was employed to prevent band-broadening, and a sufficient microLC separation was achieved to eliminate endogenous interferences and to minimize ion suppression effect. Detect limits of the four metabolites ranged from 0.5-1 pg/mL, and the linearity was excellent for all compounds. The method showed high quantitative accuracy (error < 13.8%) and precision (CV < 14.1%). For 1alpha,25-dihydroxy-VitD(3), a lower limit of quantification (LLOQ) of 5 pg/mL was validated. This high level of sensitivity, for the first time, enabled the robust and consistent LC/MS/MS-based analysis of the four metabolites in a large-scale clinical investigation. Serum samples from 281 multiple sclerosis patients and 22 healthy subjects were analyzed, and it was discovered that the levels of both 24(R),25-dihydroxy-VitD(3) and 1alpha,25-dihydroxy-VitD(3) were significantly lower in patients than healthy subjects (P < 0.05). This novel observation may imply that the incidence of multiple sclerosis is inversely associated with the levels of the two metabolites. Moreover, the method was highly robust and reproducible as evaluated extensively in the clinical analysis; therefore, it could serve as a more selective and accurate alternative to immunoassay for large-scale clinical studies. The capacity for quantification of active metabolites of vitamin D (VitD) is highly valuable to evaluate the risks and therapies for numerous diseases such as multiple sclerosis. However, the extremely low circulating levels and poor detectability of some dihydroxyl metabolites such as the 1alpha,25-dihydroxy-VitD(3) constitute a daunting challenge. Based on the combination of a selective solid-phase extraction (SPE) and a microflow liquid chromatography tandem mass spectrometry (microLC-MS/MS), we developed an ultrasensitive method for the robust, selective, and accurate quantification of four key VitD metabolites, including 25-hydroxy-VitD(2), 25-hydroxy-VitD(3), 24(R),25-dihydroxy-VitD(3), and 1alpha,25-dihydroxy-VitD(3), in serum samples. A one-step derivatization was employed to improve the ionization efficiency of the metabolites. The SPE procedure was optimized so that the analytes were selectively extracted from serum, while the sample matrix was substantially simplified. By eliminating majority of undesirable compounds from the matrix, the selective SPE enabled a high sample loading volume on the microLC column without causing overcapacity of the microLC column and thus helped to achieve ultralow detect limits in serum. An on-column sample focusing approach was employed to prevent band-broadening, and a sufficient microLC separation was achieved to eliminate endogenous interferences and to minimize ion suppression effect. Detect limits of the four metabolites ranged from 0.5-1 pg/mL, and the linearity was excellent for all compounds. The method showed high quantitative accuracy (error < 13.8%) and precision (CV < 14.1%). For 1alpha,25-dihydroxy-VitD(3), a lower limit of quantification (LLOQ) of 5 pg/mL was validated. This high level of sensitivity, for the first time, enabled the robust and consistent LC/MS/MS-based analysis of the four metabolites in a large-scale clinical investigation. Serum samples from 281 multiple sclerosis patients and 22 healthy subjects were analyzed, and it was discovered that the levels of both 24(R),25-dihydroxy-VitD(3) and 1alpha,25-dihydroxy-VitD(3) were significantly lower in patients than healthy subjects (P < 0.05). This novel observation may imply that the incidence of multiple sclerosis is inversely associated with the levels of the two metabolites. Moreover, the method was highly robust and reproducible as evaluated extensively in the clinical analysis; therefore, it could serve as a more selective and accurate alternative to immunoassay for large-scale clinical studies.The capacity for quantification of active metabolites of vitamin D (VitD) is highly valuable to evaluate the risks and therapies for numerous diseases such as multiple sclerosis. However, the extremely low circulating levels and poor detectability of some dihydroxyl metabolites such as the 1alpha,25-dihydroxy-VitD(3) constitute a daunting challenge. Based on the combination of a selective solid-phase extraction (SPE) and a microflow liquid chromatography tandem mass spectrometry (microLC-MS/MS), we developed an ultrasensitive method for the robust, selective, and accurate quantification of four key VitD metabolites, including 25-hydroxy-VitD(2), 25-hydroxy-VitD(3), 24(R),25-dihydroxy-VitD(3), and 1alpha,25-dihydroxy-VitD(3), in serum samples. A one-step derivatization was employed to improve the ionization efficiency of the metabolites. The SPE procedure was optimized so that the analytes were selectively extracted from serum, while the sample matrix was substantially simplified. By eliminating majority of undesirable compounds from the matrix, the selective SPE enabled a high sample loading volume on the microLC column without causing overcapacity of the microLC column and thus helped to achieve ultralow detect limits in serum. An on-column sample focusing approach was employed to prevent band-broadening, and a sufficient microLC separation was achieved to eliminate endogenous interferences and to minimize ion suppression effect. Detect limits of the four metabolites ranged from 0.5-1 pg/mL, and the linearity was excellent for all compounds. The method showed high quantitative accuracy (error < 13.8%) and precision (CV < 14.1%). For 1alpha,25-dihydroxy-VitD(3), a lower limit of quantification (LLOQ) of 5 pg/mL was validated. This high level of sensitivity, for the first time, enabled the robust and consistent LC/MS/MS-based analysis of the four metabolites in a large-scale clinical investigation. Serum samples from 281 multiple sclerosis patients and 22 healthy subjects were analyzed, and it was discovered that the levels of both 24(R),25-dihydroxy-VitD(3) and 1alpha,25-dihydroxy-VitD(3) were significantly lower in patients than healthy subjects (P < 0.05). This novel observation may imply that the incidence of multiple sclerosis is inversely associated with the levels of the two metabolites. Moreover, the method was highly robust and reproducible as evaluated extensively in the clinical analysis; therefore, it could serve as a more selective and accurate alternative to immunoassay for large-scale clinical studies. |
| Author | Li, Jun Qu, Jun Bang, Eunjin Duan, Xiaotao Weinstock-Guttman, Bianca Ramanathan, Murali Wang, Hao |
| Author_xml | – sequence: 1 givenname: Xiaotao surname: Duan fullname: Duan, Xiaotao organization: Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, New York 14260-1200, USA – sequence: 2 givenname: Bianca surname: Weinstock-Guttman fullname: Weinstock-Guttman, Bianca – sequence: 3 givenname: Hao surname: Wang fullname: Wang, Hao – sequence: 4 givenname: Eunjin surname: Bang fullname: Bang, Eunjin – sequence: 5 givenname: Jun surname: Li fullname: Li, Jun – sequence: 6 givenname: Murali surname: Ramanathan fullname: Ramanathan, Murali – sequence: 7 givenname: Jun surname: Qu fullname: Qu, Jun |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20151683$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkMtOHDEQRa2IKDySBT-AvGPV4Efb015GQEIkJDZhPapxVzOO_Ojxg2Q-LP-X1gQkVlUqnXtKuqfkKKaIhJxzdsWZ4NdgDRODNvsP5IQrwTo9DOLo3X5MTkv5xRjnjOtP5Fgwrrge5An5--RrhoKxuOpekO4axOomZ6G6FGmaaMHcAn1xFYKL9JYGrLBJ3lUstBUXnxfCoz2ky3Ifu3m7CCn-WcT2YLGpzR5HWhMNzuY0-fSberdrbqR2m1OAmp4zzNs9hThSV1JNM3aj8-2QD1AKLfPyZGGx5v1n8nECX_DL6zwjT9_uft7cdw-P33_cfH3ooJer2knZm2kyo9KD6KdhJZnuN5M2AyowkgvgWgBToJCjASWsldoIqZFverWA4oxc_vfOOe0alroOrlj0HiKmVtYrKfmgpDILefFKtk3AcT1nFyDv129Ni3_Eooc2 |
| CitedBy_id | crossref_primary_10_1016_j_talanta_2020_121692 crossref_primary_10_4155_bio_11_195 crossref_primary_10_1007_s11154_013_9241_0 crossref_primary_10_1002_mas_21408 crossref_primary_10_1038_srep21080 crossref_primary_10_1016_j_chroma_2011_02_004 crossref_primary_10_1038_ncomms9468 crossref_primary_10_4155_bio_2020_0038 crossref_primary_10_1016_j_jchromb_2016_04_034 crossref_primary_10_1210_jc_2012_2790 crossref_primary_10_1002_jssc_201000410 crossref_primary_10_1016_j_jpba_2016_06_024 crossref_primary_10_1007_s42000_020_00188_9 crossref_primary_10_1007_s00223_012_9693_3 crossref_primary_10_1515_cclm_2021_0441 crossref_primary_10_1016_j_trac_2018_11_008 crossref_primary_10_1016_j_clinbiochem_2012_06_030 crossref_primary_10_4155_bio_14_36 crossref_primary_10_1016_j_jchromb_2013_05_029 crossref_primary_10_1016_j_trac_2016_02_005 crossref_primary_10_1016_j_chroma_2021_462444 crossref_primary_10_4155_bio_13_283 crossref_primary_10_1002_rcm_4988 crossref_primary_10_1016_j_chroma_2021_462047 crossref_primary_10_1194_jlr_D073536 crossref_primary_10_1002_pmic_201200132 crossref_primary_10_1080_10408347_2023_2261130 crossref_primary_10_1136_jnnp_2012_304740 crossref_primary_10_1080_10408347_2024_2316237 crossref_primary_10_1373_clinchem_2015_241430 crossref_primary_10_1016_j_jchromb_2011_02_008 crossref_primary_10_3390_nu11112774 crossref_primary_10_1136_jnnp_2012_304661 crossref_primary_10_4155_bio_2020_0069 crossref_primary_10_1007_s13361_017_1775_z crossref_primary_10_1016_j_jsbmb_2014_06_007 crossref_primary_10_1371_journal_pone_0123771 crossref_primary_10_4155_bio_15_183 crossref_primary_10_4155_bio_15_260 crossref_primary_10_1016_j_aca_2015_08_017 crossref_primary_10_1016_j_biortech_2024_131078 crossref_primary_10_1007_s00216_010_3993_0 crossref_primary_10_1016_j_cca_2011_05_010 crossref_primary_10_1016_j_jchromb_2011_12_021 crossref_primary_10_1002_rcm_6708 crossref_primary_10_1016_j_chroma_2012_06_007 crossref_primary_10_4155_bio_11_298 crossref_primary_10_1002_jssc_201000911 crossref_primary_10_1016_j_jns_2011_07_024 crossref_primary_10_1016_j_clinms_2017_08_005 crossref_primary_10_1016_j_jsbmb_2023_106367 crossref_primary_10_1016_j_cca_2017_08_033 crossref_primary_10_1038_s41598_024_55939_0 crossref_primary_10_7759_cureus_92683 crossref_primary_10_4155_bio_13_300 crossref_primary_10_1016_j_chroma_2014_12_084 crossref_primary_10_1016_j_jsbmb_2018_09_003 crossref_primary_10_1002_bmc_3633 crossref_primary_10_1002_jms_1657 crossref_primary_10_1007_s12268_021_1649_6 crossref_primary_10_1371_journal_pone_0053996 crossref_primary_10_1016_j_clinbiochem_2012_03_016 crossref_primary_10_1016_j_ab_2011_06_043 crossref_primary_10_1016_j_beem_2013_06_001 crossref_primary_10_1373_clinchem_2010_161174 crossref_primary_10_1515_cclm_2016_0264 crossref_primary_10_3390_nu10040482 crossref_primary_10_3390_nu13072293 crossref_primary_10_1016_j_jsbmb_2015_10_003 crossref_primary_10_1155_2015_296531 crossref_primary_10_1080_10408363_2023_2212765 crossref_primary_10_1002_mas_21353 crossref_primary_10_3109_00365513_2014_900694 crossref_primary_10_1016_j_jchromb_2024_124088 crossref_primary_10_1016_j_chroma_2011_03_051 crossref_primary_10_1080_10408363_2022_2070595 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1021/ac902869y |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Engineering Chemistry |
| EISSN | 1520-6882 |
| ExternalDocumentID | 20151683 |
| Genre | Validation Studies Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDA NIH HHS grantid: 1R21DA027528 |
| GroupedDBID | --- -DZ -~X .DC .K2 23M 3O- 4.4 53G 55A 5GY 5RE 5VS 6J9 7~N 85S AABXI AAHBH ABBLG ABHFT ABHMW ABJNI ABLBI ABMVS ABOCM ABPPZ ABQRX ABUCX ACBEA ACGFO ACGFS ACGOD ACIWK ACJ ACKOT ACNCT ACPRK ACS ADHLV AEESW AENEX AETEA AFEFF AFRAH AGXLV AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH BKOMP CGR CS3 CUPRZ CUY CVF D0L EBS ECM ED~ EIF EJD F5P GGK GNL IH9 IHE JG~ KZ1 LG6 LMP NPM P2P PQQKQ ROL RXW TAE TN5 UHB UI2 UKR VF5 VG9 W1F WH7 X6Y XSW YZZ ZCA ~02 7X8 |
| ID | FETCH-LOGICAL-a437t-3349ff9d56824f873064bf698e5a9312a162a05a5e1e9a52cc369236e1b45bf62 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 91 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000275379300045&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1520-6882 |
| IngestDate | Fri Jul 11 16:24:31 EDT 2025 Mon Jul 21 05:59:11 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a437t-3349ff9d56824f873064bf698e5a9312a162a05a5e1e9a52cc369236e1b45bf62 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 20151683 |
| PQID | 733185359 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_733185359 pubmed_primary_20151683 |
| PublicationCentury | 2000 |
| PublicationDate | 2010-03-15 |
| PublicationDateYYYYMMDD | 2010-03-15 |
| PublicationDate_xml | – month: 03 year: 2010 text: 2010-03-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Analytical chemistry (Washington) |
| PublicationTitleAlternate | Anal Chem |
| PublicationYear | 2010 |
| SSID | ssj0011016 |
| Score | 2.3092337 |
| Snippet | The capacity for quantification of active metabolites of vitamin D (VitD) is highly valuable to evaluate the risks and therapies for numerous diseases such as... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 2488 |
| SubjectTerms | Adult Chromatography, Liquid - methods Female Humans Limit of Detection Male Mass Spectrometry - methods Middle Aged Solid Phase Extraction - methods Vitamin D - blood Vitamin D - metabolism |
| Title | Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/20151683 https://www.proquest.com/docview/733185359 |
| Volume | 82 |
| WOSCitedRecordID | wos000275379300045&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwELWgRQIOBUqBlg_NgavVOo6d-FShQsUBVj1QaW8rO7ZppE2c3SRF_DD-H2MnC1wQBy45xVaSeZ55E4_fEPIWg7Q1PHNUelxNuRE5NU5W1HlMnhEvwrtk6U_FYlEul-pqrs3p57LKnU9MjtqGKv4jP429BTG0CHXebWhsGhU3V-cOGnfJPkcmE9dlsfy9iRAT0ySXGjMkZJI7YaGMneoqqpZI9f3vxDIFmMtH__loj8nBzCzh3QSFJ-SOaw_J_YtdQ7dD8vAP7cGn5Mf1ethiCGv7VD0Em1FPdUPJVBA8IDjHBm7rQTd1C--hcQMiJp5Z7iGWy3-FPjXRiaMRwbWl3Q1OCOjut9NxCajC2K2dhSFAEyv__Dp8g3W9GWsL1c02IF2eJbNBtxbqPgyhc9TW03qABqk9pMOgUVUB3-KIXF9--HLxkc49HKjOeTFQznPlvbJCllnuyyImPMZLVTqhFWeZZjLTZ0ILx5zSIqsqLpFzSsdMLvDG7BnZa0PrXhBQyNQYQsgopH2ssLqszJksjWFW2tyoYwI786zwy8aND926MParXwY6Js8nE6-6SctjhfxHMFnyk38PfkkeTKUDnDLxiux79A_uNblX3Q51v32TsIfXxdXnn8Ij6rY |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ultrasensitive+quantification+of+serum+vitamin+D+metabolites+using+selective+solid-phase+extraction+coupled+to+microflow+liquid+chromatography+and+isotope-dilution+mass+spectrometry&rft.jtitle=Analytical+chemistry+%28Washington%29&rft.au=Duan%2C+Xiaotao&rft.au=Weinstock-Guttman%2C+Bianca&rft.au=Wang%2C+Hao&rft.au=Bang%2C+Eunjin&rft.date=2010-03-15&rft.eissn=1520-6882&rft.volume=82&rft.issue=6&rft.spage=2488&rft_id=info:doi/10.1021%2Fac902869y&rft_id=info%3Apmid%2F20151683&rft_id=info%3Apmid%2F20151683&rft.externalDocID=20151683 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1520-6882&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1520-6882&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1520-6882&client=summon |